Open in interactive viewer → charts, metric popovers & call review

Kolibri's Quarter Looked Backward; The Well Looks Forward

Production fell 9% and net income didn't budge — but a first-ever False Caney well just made a $200M micro-cap a reserve-growth story it hasn't booked yet.
KGEI · Earnings Call · 2026-11-13

The Print Reads Down. The Rate Reads Up.

Kolibri's headline numbers are a study in how a price/volume swing can invert a story. Third-quarter revenue rose 22% to $18.3 million and adjusted EBITDA climbed 20% to $13.3 million — but average production was 3,876 BOE per day, down 9% year over year. The entire delta was commodity beta: realized prices up 34%. Unsurprisingly, higher prices was the loudest phrase in the transcript, and it is not a company achievement. Everyone in the basin got that tape. What management wants you to look at instead is the exit rate. “As we mentioned in our earnings release, our current production is approximately 5,700 BOE per day with all the new wells online.” — Gary W. Johnson, Chief Financial Officer · 2026-11-13 That is roughly 47% above the quarter's average — the reported quarter is the trough, and the fourth quarter inherits the step-change. The current production line is the only number on the call that matters more than the printed ones, because the printed ones describe a period during which new wells were deliberately shut in, plus ordinary normal decline. Wall Street marks E&Ps on forward rates; on that basis this was not a down quarter.

False Caney: An Unbooked Bench Is the Whole Thesis

But the rate is not the story either. The story is the Lovina 5-8-1HF — Kolibri's first test of the False Caney interval.

We're really excited that the Lovina well is performing so well from this new interval. It's always great to have a good well, but it's even better when it's coming from a previously untested interval and it goes so well.

Wolf E. Regener, Chief Executive Officer · 2026-11-13
For a company this size, one bench can be the entire equity case. Wolf Regener notes the interval "is present over most of our property" and, crucially, that "our reserve report includes no False Caney reserves so far." That's the asymmetry: False Caney reserves are currently zero in the engineering report, so any booking is pure incremental value. “We won't get reserve report credit for it right away, but I think we'll grow into that without an issue.” — Wolf E. Regener, Chief Executive Officer · 2026-11-13 The keyword history confirms this is genuinely new, not recycled language. False Caney formation and the adjacent untested interval do not appear in the company's curated top keywords before mid-2026; they now sit near the top alongside Caney development. The older framing of the reserve report — a recurring theme going back to 2024 — has also shifted in tone. Previously it was about booked value and NPV; this quarter it is explicitly about what is not in it yet. That is a meaningfully different conversation. The caveat is honesty about sample size. This is a single well, and the analyst on the call flagged that it was "a slightly shorter lateral than planned." Management's answer — that extrapolating to a normal two-mile lateral would produce healthy rates on a per-foot basis — is arithmetic, not evidence. “It's been strong. It's been steady. And I've got 0 complaints about this well.” — Wolf E. Regener, Chief Executive Officer · 2026-11-13 One well is a data point. Management also flagged the T-zone below as a proven bench not yet in the report, implying multiple undeveloped intervals stacked across the same acreage.

The Hedges Cut Both Ways

Here is the irony buried in the income statement. Net income was flat at $3.6 million with $0.10 EPS despite 22% revenue growth — because of a $2.4 million noncash mark-to-market on commodity contracts plus a realized loss on hedges. Netback from operations ex-hedges rose 41% to $43.48 per BOE; including hedges it was $40.55. Why does that sting? Because the hedging was not a view — it was a credit-facility requirement. Back in May, Regener laid out the posture plainly: “If you can hedge in $90 to $100 longer term, you should probably do that for a portion of your production.” — Wolf E. Regener, Chief Executive Officer · 2026-05-14 They did exactly that, and the subsequent rally turned a prudent, lender-mandated program into a visible drag. The balance sheet is still comfortable — net debt of $15.4 million, $75 million borrowing base reaffirmed in October, $19.5 million undrawn — and the CEO was happy to point out that “our debt to EBITDA, keeping it down low, we've got a lot of room to run even if we wanted to take on some additional debt, we could.” — Wolf E. Regener, Chief Executive Officer · 2026-11-13 But the quarter is a reminder that at this scale, financing terms set your commodity exposure.

Cost Creep and a Softer Guide

Operating expense rose 14% to $8.39 per BOE, driven by severance taxes on higher prices, workover costs on a non-operated well, and stubborn higher chemical costs. That last one matters because it contradicts a prior claim. In May, asked directly about inflation, the answer was: “No, not yet. Not yet, not on the operating side of things, and that shouldn't really change. Most of our costs are pretty locked in.” — Wolf E. Regener, Chief Executive Officer · 2026-05-14 Two quarters later, chemical costs have escalated twice in a row. The claim may be economically fair over a full cycle, but "locked in" has quietly expired as a talking point. Guidance softened in tone as well:

I think we'll be within that range, probably a little on the lower end just because these wells came on a little bit later than we had anticipated so that affects. But we should be in that ballpark.

Wolf E. Regener, Chief Executive Officer · 2026-11-13
Compare that to August, when pressed on the same guide and refusing to lean: “Sorry, I'm not going to speculate. No offense.” — Wolf E. Regener, Chief Executive Officer · 2026-08-13 The refusal has become a soft tilt to the low end. That is not a crisis — the wells are flowing — but it is a second consecutive quarter where timing slipped.

What Went Quiet

The most telling silence is capital return. buyback program was a top-tier theme as recently as 2024, and in May management listed share repurchases alongside drilling and debt paydown as one of three uses for excess cash. On this call, buybacks did not come up once. Instead: "we'll have Plan B and Plan C" for higher or lower oil prices, framed around drilling pace. When the stock is "down a little bit today along the rest of the market" and the CEO is telling non-shareholders to "take a look," a vanished buyback line is a real change in capital allocation intent. Also fading: Clifton Mack, the three-well program that dominated the prior quarter's keywords before falling sharply this quarter — because it is drilled and now simply returning frac fluid. And the gassier southwest corner remains an open question the analyst raised; management expects oil cuts to recover as load fluid clears, but that is a hope, not a measurement.

The Market Isn't Helping

Zoom out. The curated global keyword set for the latest quarter is dominated by rates, AI agents and regulatory arcana — energy is essentially absent from the market's editorial attention. Where oil does show up among recent reporters, it is as raw price realization: VLE.TO's oil price and Aval's Oil prices. Meanwhile the 30-day price tape shows fuel-cost themes slipping into the decliners list. Translation: the 34% price tailwind that carried this quarter's revenue is a gift that may not repeat, and it is outside management's control. So what are you actually buying at roughly $200 million of market cap? A levered-to-nothing operator with $15.4 million of net debt, $19.5 million of undrawn capacity, a production base that just stepped up meaningfully, and — the point — an interval that appears across most of the acreage and carries zero engineering credit. The catalyst is specific and measurable: a 30-day rate on one well. The risk is equally specific: it is one well, in one corner of one field, and the rest is extrapolation.